Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-08-15
著者
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
UTSUNOMIYA Atae
Department of Hematology, Imamura Bun-in Hospital
-
TANOSAKI Ryuji
Stem Cell Transplant Unit, National Cancer Center Hospital
-
Tanosaki Ryuji
Stem Cell Transplantation Unit National Cancer Center Hospital
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center
-
OKAMURA Jun
Institute for Clinical Research National Kyushu Cancer Center
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Utsunomiya Atae
Department Of Hematology Imamura Bun-in Hospital
-
Utsunomiya Atae
東京医科歯科大学 免疫治療学
-
Okamura Jun
東京医科歯科大学 免疫治療学
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- An Immunohistochemical Analysis of Peripheral Blood Tissue Specimens from Leukemia Cells : Leukemic Cells of Adult T-cell Leukemia/Lymphoma Express p40Tax Protein of Human T-cell Lymphotropic Virus Type 1 When Entering Reproliferation
- Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF)
- Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia
- Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia
- Severe Aplastic Anemia Associated With Chronic Natural Killer Cell Lymphocytosis
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- Case-control study of leukemia and diagnostic radiation exposure
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Expression of Human Tumor-Associated Antigen RCAS1 in Adult T-Cell Leukemia/Lymphoma
- Gene Expression in Adult T Cell Leukemia/Lymphoma : Up-Regulation of Matrix Metalloproteinase 2 in Skin Lesions
- Association of High Proliferation in Adult T-cell Leukemia Cells With Apoptosis, and Expression of p53 Protein in Acute Type ATL
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Epstein-Barr virus-associated enteritis with multiple ulcers after stem cell transplantation : First histologically confirmed case
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Oncogene Associated cDNA Microarray Analysis Shows PRAME Gene Expression is a Marker for Response to Anthracycline Containing Chemotherapy in Patients with Diffuse Large B-cell Lymphoma
- Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia
- Phase I Study of the Combination of Irinotecan Hydrochloride, Carbplatin, and Dexamethasone for the Treatment of Relapsed or Refractory Malignanty Lymphoma
- Late effects and quality of life of childhood cancer survivors : Part 2. Impact of radiotherapy
- Late effects and quality of life of childhood cancer survivors : Part 1. Impact of stem cell transplantation
- Detection of NOTCH1 Mutations in Adult T-Cell Leukemia/Lymphoma and Peripheral T-Cell Lymphoma
- Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan : A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
- Crusted scabies in an adult T-cell leukemia/lymphoma patient successfully treated with oral ivermectin
- Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1
- Successful Combination Therapy with Trastuzumab and Paclitaxel for Adriamycin- and Docetaxel-Resistant Inflammatory Breast Cancer
- Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages
- A Family Predisposition to Adult T-Cell Leukemia
- Expression of the TCL1 Gene at 14q32 in B-Cell Malignancies but Not in Adult T-Cell Leukemia
- Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma
- Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients
- Carcinoembryonic Antigen-Producing Multiple Myeloma Detected by a Transcription-Reverse Transcription Concerted Reaction System
- Toxicity and Outcome of Intensive Chemotherapy for Acute Lymphoblastic Leukemia Complicated with Turner's Syndrome
- CD2^+ Tetraploid Acute Promyelocytic Leukemia Variant with Double (15 ; 17) Translocations
- Th1/Th2 Lymphocyte Balance in Patients with Aplastic Anemia
- Successful Immunosuppressive Therapy with Cyclosporine A for Posthepatitis B-Cell Deficiency With Activated Cytoplasmic Interferon-γ-Positive T-Lymphocytes
- Monitoring Minimal Residual Disease in Patients With MLL-AF6 Fusion Transcript-Positive Acute Myeloid leukemia Fllowing Allogeneic Bone Marrow Transplantation
- Renal vein lymphoma embolism in non-Hodgkin lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Residential Proximity to High-Voltage Power Lines and Risk of Childhood Hematological Malignancies
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Two Cases of Mediastinal Gray Zone Lymphoma
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- 日本の小児がん経験者の病院受診動向 : 横断調査研究
- Social outcomes and quality of life of childhood cancer survivors in Japan : a cross-sectional study on marriage, education, employment and health-related QOL (SF-36)
- Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies : analysis of eight patients
- Potential macrophage-T progenitor origin of systemic anaplastic large cell lymphoma
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin